2006
DOI: 10.1016/j.leukres.2006.04.001
|View full text |Cite
|
Sign up to set email alerts
|

Aberrant DNA demethylation in promoter region and aberrant expression of mRNA of PAX4 gene in hematologic malignancies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
16
0
2

Year Published

2007
2007
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 18 publications
(18 citation statements)
references
References 25 publications
0
16
0
2
Order By: Relevance
“…Furthermore, aberrant DNA demethylation in the promoter region of the pax4 gene was recently associated with induced expression of the transcript and development of haematologic malignancies (Li et al, 2006). These results clearly implicate the transcription factor in tumorigenesis.…”
Section: Introductionmentioning
confidence: 83%
“…Furthermore, aberrant DNA demethylation in the promoter region of the pax4 gene was recently associated with induced expression of the transcript and development of haematologic malignancies (Li et al, 2006). These results clearly implicate the transcription factor in tumorigenesis.…”
Section: Introductionmentioning
confidence: 83%
“…Mutations in this gene are associated with obesity, tumorigenesis, and metastasis (Tzimas et al, 2005). The PAX4 gene, located in 7q32, is a member of the paired box family of transcription factor that mediates differentiation of insulin-producing beta-cells in the pancreas and plays critical roles during cancer growth (Li et al, 2006). EGFR is a transmembrane glycoprotein that functions as a tyrosine protein kinase (Kondo and Shimizu, 1983).…”
Section: Discussionmentioning
confidence: 99%
“…Treatment of rat islets with a DNA-methyltransferase inhibitor, 5′AZA, stimulates endogenous Pax4 expression and consequently expression of its downstream target Bcl-xL , suggesting that demethylation of Pax4 promoter is an epigenetic modification controlling Pax4 expression [34]. Moreover, demethylation of the human PAX4 promoter region located −1347 to −1103 bp from translation initiation site (Figure 2A) has been linked to aberrant expression of PAX4 in lymph nodes of patients with diffuse large B cell lymphoma (DLBCL) as well as in several hematological cell lines [73]. Of note, hematological organs do not express PAX4 under physiological conditions.…”
Section: Pax4 Regulationmentioning
confidence: 99%